Evaluation of adalimumab effects in managing severe cases of COVID-19: A randomized controlled trial

DOI record: { "DOI": "10.1016/j.intimp.2021.107961", "ISSN": [ "1567-5769" ], "URL": "http://dx.doi.org/10.1016/j.intimp.2021.107961", "alternative-id": [ "S156757692100597X" ], "article-number": "107961", "assertion": [ { "label": "This article is maintained by", "name": "publisher", "value": "Elsevier" }, { "label": "Article Title", "name": "articletitle", "value": "Evaluation of adalimumab effects in managing severe cases of COVID-19: A randomized controlled trial" }, { "label": "Journal Title", "name": "journaltitle", "value": "International Immunopharmacology" }, { "label": "CrossRef DOI link to publisher maintained version", "name": "articlelink", "value": "https://doi.org/10.1016/j.intimp.2021.107961" }, { "label": "Content Type", "name": "content_type", "value": "article" }, { "label": "Copyright", "name": "copyright", "value": "© 2021 Elsevier B.V. All rights reserved." } ], "author": [ { "affiliation": [], "family": "Fakharian", "given": "Atefeh", "sequence": "first" }, { "affiliation": [], "family": "Barati", "given": "Saghar", "sequence": "additional" }, { "affiliation": [], "family": "Mirenayat", "given": "Maryam", "sequence": "additional" }, { "affiliation": [], "family": "Rezaei", "given": "Mitra", "sequence": "additional" }, { "affiliation": [], "family": "Haseli", "given": "Sara", "sequence": "additional" }, { "affiliation": [], "family": "Torkaman", "given": "Pooria", "sequence": "additional" }, { "affiliation": [], "family": "Yousefian", "given": "Sahar", "sequence": "additional" }, { "affiliation": [], "family": "Dastan", "given": "Alireza", "sequence": "additional" }, { "affiliation": [], "family": "jamaati", "given": "Hamidreza", "sequence": "additional" }, { "affiliation": [], "family": "Dastan", "given": "Farzaneh", "sequence": "additional" } ], "container-title": "International Immunopharmacology", "container-title-short": "International Immunopharmacology", "content-domain": { "crossmark-restriction": true, "domain": [ "elsevier.com", "sciencedirect.com" ] }, "created": { "date-parts": [ [ 2021, 7, 7 ] ], "date-time": "2021-07-07T07:43:52Z", "timestamp": 1625643832000 }, "deposited": { "date-parts": [ [ 2024, 11, 5 ] ], "date-time": "2024-11-05T20:13:37Z", "timestamp": 1730837617000 }, "funder": [ { "DOI": "10.13039/501100005851", "doi-asserted-by": "publisher", "id": [ { "asserted-by": "publisher", "id": "10.13039/501100005851", "id-type": "DOI" } ], "name": "Shahid Beheshti University of Medical Sciences" } ], "indexed": { "date-parts": [ [ 2025, 2, 21 ] ], "date-time": "2025-02-21T04:40:29Z", "timestamp": 1740112829003, "version": "3.37.3" }, "is-referenced-by-count": 25, "issued": { "date-parts": [ [ 2021, 10 ] ] }, "language": "en", "license": [ { "URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2021, 10, 1 ] ], "date-time": "2021-10-01T00:00:00Z", "timestamp": 1633046400000 } }, { "URL": "https://www.elsevier.com/legal/tdmrep-license", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2021, 10, 1 ] ], "date-time": "2021-10-01T00:00:00Z", "timestamp": 1633046400000 } }, { "URL": "https://doi.org/10.15223/policy-017", "content-version": "stm-asf", "delay-in-days": 0, "start": { "date-parts": [ [ 2021, 10, 1 ] ], "date-time": "2021-10-01T00:00:00Z", "timestamp": 1633046400000 } }, { "URL": "https://doi.org/10.15223/policy-037", "content-version": "stm-asf", "delay-in-days": 0, "start": { "date-parts": [ [ 2021, 10, 1 ] ], "date-time": "2021-10-01T00:00:00Z", "timestamp": 1633046400000 } }, { "URL": "https://doi.org/10.15223/policy-012", "content-version": "stm-asf", "delay-in-days": 0, "start": { "date-parts": [ [ 2021, 10, 1 ] ], "date-time": "2021-10-01T00:00:00Z", "timestamp": 1633046400000 } }, { "URL": "https://doi.org/10.15223/policy-029", "content-version": "stm-asf", "delay-in-days": 0, "start": { "date-parts": [ [ 2021, 10, 1 ] ], "date-time": "2021-10-01T00:00:00Z", "timestamp": 1633046400000 } }, { "URL": "https://doi.org/10.15223/policy-004", "content-version": "stm-asf", "delay-in-days": 0, "start": { "date-parts": [ [ 2021, 10, 1 ] ], "date-time": "2021-10-01T00:00:00Z", "timestamp": 1633046400000 } } ], "link": [ { "URL": "https://api.elsevier.com/content/article/PII:S156757692100597X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://api.elsevier.com/content/article/PII:S156757692100597X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining" } ], "member": "78", "original-title": [], "page": "107961", "prefix": "10.1016", "published": { "date-parts": [ [ 2021, 10 ] ] }, "published-print": { "date-parts": [ [ 2021, 10 ] ] }, "publisher": "Elsevier BV", "reference": [ { "DOI": "10.1016/j.immuni.2020.05.002", "article-title": "Immunology of COVID-19: Current State of the Science", "author": "Vabret", "doi-asserted-by": "crossref", "first-page": "910", "issue": "6", "journal-title": "Immunity", "key": "10.1016/j.intimp.2021.107961_b0005", "volume": "52", "year": "2020" }, { "DOI": "10.1016/j.clim.2020.108459", "article-title": "Immunoglobulins in the treatment of COVID-19 infection: Proceed with caution!", "author": "Nguyen", "doi-asserted-by": "crossref", "journal-title": "Clinical Immunology", "key": "10.1016/j.intimp.2021.107961_b0010", "volume": "216", "year": "2020" }, { "DOI": "10.1016/S1473-3099(20)30243-7", "article-title": "Estimates of the severity of coronavirus disease 2019: a model-based analysis", "author": "Verity", "doi-asserted-by": "crossref", "first-page": "669", "issue": "6", "journal-title": "Lancet Infect Dis", "key": "10.1016/j.intimp.2021.107961_b0015", "volume": "20", "year": "2020" }, { "DOI": "10.1001/jama.2020.1585", "article-title": "Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan", "author": "Wang", "doi-asserted-by": "crossref", "first-page": "1061", "issue": "11", "journal-title": "China. JAMA", "key": "10.1016/j.intimp.2021.107961_b0020", "volume": "323", "year": "2020" }, { "DOI": "10.1056/NEJMoa2002032", "article-title": "Clinical Characteristics of Coronavirus Disease 2019 in China", "author": "Guan", "doi-asserted-by": "crossref", "first-page": "1708", "issue": "18", "journal-title": "New England Journal of Medicine", "key": "10.1016/j.intimp.2021.107961_b0025", "volume": "382", "year": "2020" }, { "DOI": "10.1016/j.ijantimicag.2020.105924", "article-title": "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges", "author": "Lai", "doi-asserted-by": "crossref", "issue": "3", "journal-title": "International Journal of Antimicrobial Agents", "key": "10.1016/j.intimp.2021.107961_b0030", "volume": "55", "year": "2020" }, { "article-title": "An Update on Current Therapeutic Drugs Treating COVID-19", "author": "Wu", "first-page": "1", "journal-title": "Current pharmacology reports", "key": "10.1016/j.intimp.2021.107961_b0035", "year": "2020" }, { "DOI": "10.1128/AAC.00343-13", "article-title": "How does colistin-induced nephropathy develop and can it be treated?", "author": "Ozkan", "doi-asserted-by": "crossref", "first-page": "3463", "issue": "8", "journal-title": "Antimicrobial agents and chemotherapy", "key": "10.1016/j.intimp.2021.107961_b0040", "volume": "57", "year": "2013" }, { "DOI": "10.1016/S0140-6736(20)30566-3", "article-title": "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study", "author": "Zhou", "doi-asserted-by": "crossref", "first-page": "1054", "issue": "10229", "journal-title": "Lancet", "key": "10.1016/j.intimp.2021.107961_b0045", "volume": "395", "year": "2020" }, { "DOI": "10.1016/j.intimp.2020.106869", "doi-asserted-by": "crossref", "key": "10.1016/j.intimp.2021.107961_b0050", "unstructured": "Dastan, F., et al., Promising effects of tocilizumab in COVID-19: A non-controlled, prospective clinical trial. International immunopharmacology, 2020. 88: p. 106869-106869." }, { "DOI": "10.1172/JCI137244", "article-title": "Clinical and immunological features of severe and moderate coronavirus disease 2019", "author": "Chen", "doi-asserted-by": "crossref", "issue": "5", "journal-title": "The Journal of clinical investigation", "key": "10.1016/j.intimp.2021.107961_b0055", "volume": "130", "year": "2020" }, { "article-title": "Successful Management of COVID-19 With Adalimumab in a Post-Coronary Artery Bypass Graft Surgery Patient", "author": "Fakharian", "journal-title": "J Cardiothorac Vasc Anesth", "key": "10.1016/j.intimp.2021.107961_b0060", "year": "2021" }, { "DOI": "10.1016/S0140-6736(20)30858-8", "article-title": "Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed", "author": "Feldmann", "doi-asserted-by": "crossref", "first-page": "1407", "issue": "10234", "journal-title": "The Lancet", "key": "10.1016/j.intimp.2021.107961_b0065", "volume": "395", "year": "2020" }, { "DOI": "10.1093/ofid/ofaa249", "article-title": "Coronavirus Disease 2019: Associated Multiple Organ Damage", "author": "Collange", "doi-asserted-by": "crossref", "first-page": "p. ofaa249", "issue": "7", "journal-title": "Open Forum Infect Dis", "key": "10.1016/j.intimp.2021.107961_b0070", "volume": "7", "year": "2020" }, { "DOI": "10.1016/j.medidd.2020.100052", "article-title": "Inhibition of metalloproteinases in therapy for severe lung injury due to COVID-19", "author": "Solun", "doi-asserted-by": "crossref", "journal-title": "Med Drug Discov", "key": "10.1016/j.intimp.2021.107961_b0075", "volume": "7", "year": "2020" }, { "DOI": "10.1056/NEJMoa2035389", "article-title": "Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine", "author": "Baden", "doi-asserted-by": "crossref", "first-page": "403", "issue": "5", "journal-title": "N Engl J Med", "key": "10.1016/j.intimp.2021.107961_b0080", "volume": "384", "year": "2021" }, { "article-title": "COVID-19 in patients with rheumatological diseases treated with anti-TNF", "author": "Brito", "journal-title": "Annals of the rheumatic diseases", "key": "10.1016/j.intimp.2021.107961_b0085", "year": "2020" }, { "DOI": "10.1136/gutjnl-2020-321240", "article-title": "COVID-19 infection in Crohn’s disease under treatment with adalimumab", "author": "Tursi", "doi-asserted-by": "crossref", "first-page": "1364", "issue": "7", "journal-title": "Gut", "key": "10.1016/j.intimp.2021.107961_b0090", "volume": "69", "year": "2020" }, { "DOI": "10.1111/jdv.16587", "article-title": "Evolution of COVID-19 infection in 4 psoriatic patients treated with biological drugs", "author": "Conti", "doi-asserted-by": "crossref", "journal-title": "Journal of the European Academy of Dermatology and Venereology", "key": "10.1016/j.intimp.2021.107961_b0095", "year": "2020" }, { "DOI": "10.3906/sag-2004-168", "article-title": "COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs", "author": "Tufan", "doi-asserted-by": "crossref", "first-page": "620", "issue": "SI-1", "journal-title": "Turk J Med Sci", "key": "10.1016/j.intimp.2021.107961_b0100", "volume": "50", "year": "2020" }, { "DOI": "10.1093/ibd/izaa114", "doi-asserted-by": "crossref", "key": "10.1016/j.intimp.2021.107961_b0105", "unstructured": "Tursi, A., L.M. Vetrone, and A. Papa, Anti-TNF-α Agents in Inflammatory Bowel Disease and Course of COVID-19. Inflammatory Bowel Diseases, 2020. 26(7): p. e73-e73." }, { "DOI": "10.1177/1753466620926800", "doi-asserted-by": "crossref", "key": "10.1016/j.intimp.2021.107961_b0110", "unstructured": "Chen, X.Y., B.X. Yan, and X.Y. Man, TNFα inhibitor may be effective for severe COVID-19: learning from toxic epidermal necrolysis. Ther Adv Respir Dis, 2020. 14: p. 1753466620926800." }, { "DOI": "10.1038/s41591-020-1051-9", "article-title": "An inflammatory cytokine signature predicts COVID-19 severity and survival", "author": "Del Valle", "doi-asserted-by": "crossref", "first-page": "1636", "issue": "10", "journal-title": "Nat Med", "key": "10.1016/j.intimp.2021.107961_b0115", "volume": "26", "year": "2020" }, { "DOI": "10.1183/16000617.0287-2020", "article-title": "Updated guidance on the management of COVID-19: from an American Thoracic Society/European Respiratory Society coordinated International Task Force (29 July 2020)", "author": "Bai", "doi-asserted-by": "crossref", "issue": "157", "journal-title": "Eur Respir Rev", "key": "10.1016/j.intimp.2021.107961_b0120", "volume": "29", "year": "2020" } ], "reference-count": 24, "references-count": 24, "relation": {}, "resource": { "primary": { "URL": "https://linkinghub.elsevier.com/retrieve/pii/S156757692100597X" } }, "score": 1, "short-title": [], "source": "Crossref", "special_numbering": "C", "subject": [], "subtitle": [], "title": "Evaluation of adalimumab effects in managing severe cases of COVID-19: A randomized controlled trial", "type": "journal-article", "update-policy": "https://doi.org/10.1016/elsevier_cm_policy", "volume": "99" }